Clinical Trial Update: Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Gliadel Wafer with Temozolomide and radiation for newly diagnosed glioblastoma multiforme/high-grade glioma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• High-grade Glioma

Drugs mentioned

• GLIADEL wafer (carmustine)
• Temodar (Temozolomide)

Snippet

Sponsor: Methodist Healthcare | Conditions: Glioblastoma Multiforme, High-Grade Glioma | Phase 2 | Status: TERMINATED